Healthcare provider profile · identity verified

Matthew S Brett, MD

Family Practice · LONGMONT, CO · NPI 1285610964

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	261	71
Lisinopril	Lisinopril	241	65
Morphine Sulfate Er	Morphine Sulfate	183	18
Levothyroxine Sodium	Levothyroxine Sodium	170	41
Oxycodone Hcl	Oxycodone Hcl	160	20
Omeprazole	Omeprazole	142	32
Amlodipine Besylate	Amlodipine Besylate	140	46
Losartan Potassium	Losartan Potassium	132	43
Pantoprazole Sodium	Pantoprazole Sodium	132	35
Gabapentin	Gabapentin	116	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	115	24
Rosuvastatin Calcium	Rosuvastatin Calcium	102	30
Tamsulosin Hcl	Tamsulosin Hcl	93	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	84	19
Zolpidem Tartrate	Zolpidem Tartrate	81	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	12
Trazodone Hcl	Trazodone Hcl	78	13
Fluticasone Propionate	Fluticasone Propionate	74	29
Metformin Hcl	Metformin Hcl	73	26
Eliquis	Apixaban	70	12
Albuterol Sulfate Hfa	Albuterol Sulfate	67	27
Diazepam	Diazepam	63	11
Clonazepam	Clonazepam	60	11
Metoprolol Succinate	Metoprolol Succinate	60	16
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	54	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	52	suppressed
Carvedilol	Carvedilol	52	16
Pregabalin	Pregabalin	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Prednisone	Prednisone	48	24
Alprazolam	Alprazolam	45	suppressed
Simvastatin	Simvastatin	45	13
Jardiance	Empagliflozin	44	13
Metoprolol Tartrate	Metoprolol Tartrate	44	12
Olanzapine	Olanzapine	43	suppressed
Aripiprazole	Aripiprazole	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	11
Famotidine	Famotidine	40	16
Spironolactone	Spironolactone	38	13
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Morphine Sulfate	Morphine Sulfate	37	suppressed
Ozempic	Semaglutide	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Topiramate	Topiramate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	19
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Divalproex Sodium Er	Divalproex Sodium	31	suppressed
Allopurinol	Allopurinol	30	13
Furosemide	Furosemide	30	11
Tramadol Hcl	Tramadol Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Cephalexin	Cephalexin	27	18
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Ibu	Ibuprofen	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Azithromycin	Azithromycin	22	16
Verapamil Er	Verapamil Hcl	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	15
Myrbetriq	Mirabegron	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Meloxicam	Meloxicam	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Ondansetron Odt	Ondansetron	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Finasteride	Finasteride	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Baclofen	Baclofen	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Proair Respiclick	Albuterol Sulfate	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error